The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on percutaneous cryotherapy for renal tumours.

This document replaces previous guidance on cryotherapy for renal cancers (NICE interventional procedure guidance 207, January 2007).


Renal cancer occurs in the lining of the very small tubes in the kidney. Cryotherapy uses cold temperatures to destroy cancer cells through the insertion of a surgical instrument that applies freezing temperatures (cryoprobe) into the tumour.

Coding recommendations

M13.8 Other specified percutaneous puncture of kidney

Y13.2 Cryotherapy to lesion of organ NOC

Y53.- Approach to organ under image control

Note: Codes within category Y53.- are used as secondary codes to classify interventions that are percutaneous and require some form of image control: if the method of image control is unspecified, Y53.9 Unspecified approach to organ under image control is assigned.  

In addition ICD-10 codes C64.X Malignant neoplasm of kidney, except renal pelvis, C65.X Malignant neoplasm of renal pelvis orC79.0 Secondary malignant neoplasm of kidney and renal pelvis are assigned for renal malignancies or D30.0 Benign neoplasm of kidney or D30.1 Benign neoplasm of renal pelvis for benign neoplasms of the kidney.

  • National Institute for Health and Care Excellence (NICE) accreditation logo